Skip to main content

CITADEL ADVISORS LLC

Position in LPCN — Lipocine Inc.

CIK 1423053 MIAMI, FL

Position in LPCN

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$207,925
-$24,487 QoQ
Shares Held
81,221
+179.2% QoQ
Ownership
0.985%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 36 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LPCN Over Time

Shares Held

Position Value (USD)

Derivatives in LPCN

reported options exposure · as of Mar 31, 2023
CallValue
$9,476
CallShares
1,753
PutValue
$286
PutShares
53

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. LPCN ranks #315 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LPCN

Export CSV
35 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $207,925 81,221
2026-03-31 $232,412 29,088
2025-09-30 $40,603 14,247
2023-03-31 $9,476 29,800
2023-03-31 $29,698 93,393
2023-03-31 $286 900
2022-12-31 $4,855 12,200
2022-12-31 $36,257 91,100
2022-12-31 $42,423 106,592
2022-09-30 $32,760 72,800
2022-09-30 $132,936 295,416
2022-09-30 $5,535 12,300
2022-06-30 $69,767 87,100
2022-06-30 $9,692 12,100
2022-03-31 $108,504 79,200
2022-03-31 $86,494 63,135
2022-03-31 $57,540 42,000
2021-12-31 $161,533 163,000
2021-12-31 $35,283 35,605
2021-12-31 $24,180 24,400
2021-09-30 $58,097 53,300
2021-09-30 $237,729 218,100
2021-09-30 $60,625 55,620
2021-06-30 $77,420 55,300
2021-06-30 $282,100 201,500
2021-03-31 $63,075 41,772
2021-03-31 $136,806 90,600
2021-03-31 $234,201 155,100
2020-12-31 $101,848 74,889
2020-12-31 $92,752 68,200
2020-09-30 $77,127 54,700
2020-09-30 $17,100 12,128
2020-06-30 $21,798 17,300
2020-03-31 $5,883 12,257
2020-03-31 $6,576 13,700